Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Lung Neoplasms, Lymphoma, Non-Hodgkin, Melanoma, Neoplasm Metastasis, Neoplasms, Recurrence, Sarcoma, Kaposi, HIV Infections

NCT01328535 2020-10-22

Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Phase 2 Completed

25 enrolled 8 charts

Dermatologic

Melanoma

NCT00568763 2018-10-31

Radiofrequency Therapy-Induced Endogenous Heat-Shock Proteins With or Without Radiofrequency Ablation or Cryotherapy in Treating Patients With Stage IV Melanoma

Phase 1 Completed

11 enrolled

Dermatologic

Melanoma

NCT00715793 2017-10-03

UPCI-07-008

Phase 1/2 Completed

39 enrolled 12 charts

Dermatologic

Melanoma, Neoplasm Metastasis, Skin Neoplasms

NCT00871481 2017-04-19

Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma

Phase 1/2 Completed

10 enrolled

Dermatologic

Melanoma

NCT00553306 2017-02-15

Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma

Phase 1/2 Completed

10 enrolled

Dermatologic

Melanoma

NCT00705640 2016-12-16

Mel48

Phase 1 Completed

45 enrolled

Dermatologic

Uveal Melanoma, Melanoma

NCT00900302 2016-02-10

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Completed

98 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Anus Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Melanoma, Neoplasms, Neoplasms, Unknown Primary, Penile Neoplasms, Salivary Gland Neoplasms, Skin Neoplasms, Vulvar Neoplasms, Breast Neoplasms, Male

NCT00462280 2014-10-31

Lovastatin in Treating Patients At High Risk of Melanoma

Phase 2 Completed

80 enrolled 35 charts

DermatologicOther neoplasm

Melanoma, Precancerous Conditions

NCT00824889 2014-08-29

Exploratory Study of Natural Killer Cells in Human Skin

Phase NA Completed

28 enrolled

Dermatologic

Dermatitis, Atopic, Dermatitis, Contact, Graft vs Host Disease, Lichen Planus, Melanoma, Psoriasis

NCT00466687 2013-07-22

Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma

Phase 2 Completed

34 enrolled 10 charts

Dermatologic

Melanoma

NCT00438984 2012-03-16

Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma

Phase 1 Completed

11 enrolled

Dermatologic

Melanoma

NCT00602199 2011-05-16

ABT-510 in Treating Patients With Metastatic Melanoma

Phase 2 Completed

42 enrolled

Dermatologic

Melanoma

Clinical Trials

Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma

Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma

Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma

Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Radiofrequency Therapy-Induced Endogenous Heat-Shock Proteins With or Without Radiofrequency Ablation or Cryotherapy in Treating Patients With Stage IV Melanoma

UPCI-07-008

Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma

Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma

Mel48

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Lovastatin in Treating Patients At High Risk of Melanoma

Exploratory Study of Natural Killer Cells in Human Skin

Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma

Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma

ABT-510 in Treating Patients With Metastatic Melanoma